Predictions
Medigene AG
Start price
Target price
Perf. (%)
€3.71
22.02.22
22.02.22
€5.00
22.02.23
22.02.23
18.89%
23.02.22
23.02.22
Could be very worthwhile Investment >20% year
Very capable Management
Good culture
Little innovation
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€8.98
21.02.21
21.02.21
€10.00
21.02.22
21.02.22
-54.90%
22.02.22
22.02.22
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Known brand
Very Future proof/growth oriented business model
Vita 34 AG
Start price
Target price
Perf. (%)
€15.55
21.02.21
21.02.21
-
21.02.22
21.02.22
-25.08%
22.02.22
22.02.22
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Formycon AG
Start price
Target price
Perf. (%)
€67.40
07.02.21
07.02.21
€80.00
07.02.22
07.02.22
-20.03%
08.02.22
08.02.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
Low dividend yield expected
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€36.24
01.02.21
01.02.21
€40.00
01.02.22
01.02.22
1.56%
01.02.22
01.02.22
MPH Health Care AG
Start price
Target price
Perf. (%)
€26.00
16.05.21
16.05.21
€40.00
16.05.22
16.05.22
-5.77%
29.01.22
29.01.22
Could be very worthwhile Investment >20% year
Undervalued
Future proof or reliable business model
Significant cyclical dependencies
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€38.44
27.01.21
27.01.21
€45.00
27.01.22
27.01.22
-4.29%
28.01.22
28.01.22
Could be worthwhile Investment >10% per year
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€67.80
23.01.21
23.01.21
€88.00
23.01.22
23.01.22
-26.99%
24.01.22
24.01.22
Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€71.80
23.01.21
23.01.21
€88.00
23.01.22
23.01.22
-30.36%
24.01.22
24.01.22
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Bio-Gate AG
Start price
Target price
Perf. (%)
€4.14
09.01.22
09.01.22
-
09.01.23
09.01.23
-5.80%
23.01.22
23.01.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€123.30
17.08.21
17.08.21
-
17.08.22
17.08.22
-27.01%
12.01.22
12.01.22
Mediclin AG
Start price
Target price
Perf. (%)
€4.36
10.01.21
10.01.21
€6.00
10.01.22
10.01.22
-15.14%
11.01.22
11.01.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Stratec SE
Start price
Target price
Perf. (%)
€122.40
30.12.20
30.12.20
€128.00
30.12.21
30.12.21
12.75%
31.12.21
31.12.21
Could be worthwhile Investment >10% per year
Formycon AG
Start price
Target price
Perf. (%)
€66.90
18.04.21
18.04.21
-
18.04.22
18.04.22
-16.59%
21.12.21
21.12.21
Could be worthwhile Investment >10% per year
Merck KGaA
Start price
Target price
Perf. (%)
€144.40
25.03.21
25.03.21
€130.00
25.03.22
25.03.22
56.79%
14.12.21
14.12.21
Some uniques
Future proof or reliable business model
overvalued
Low dividend yield expected